ITMI20031291A0 - Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale - Google Patents

Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale

Info

Publication number
ITMI20031291A0
ITMI20031291A0 IT2003MI001291A ITMI20031291A ITMI20031291A0 IT MI20031291 A0 ITMI20031291 A0 IT MI20031291A0 IT 2003MI001291 A IT2003MI001291 A IT 2003MI001291A IT MI20031291 A ITMI20031291 A IT MI20031291A IT MI20031291 A0 ITMI20031291 A0 IT MI20031291A0
Authority
IT
Italy
Prior art keywords
mouth
compositions
preparation
treatment
hyaluronic acid
Prior art date
Application number
IT2003MI001291A
Other languages
English (en)
Inventor
Franco Macchia
Original Assignee
Ricerfarma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30131290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI20031291(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ricerfarma Srl filed Critical Ricerfarma Srl
Priority to IT001291A priority Critical patent/ITMI20031291A1/it
Publication of ITMI20031291A0 publication Critical patent/ITMI20031291A0/it
Priority to MXPA05014184A priority patent/MXPA05014184A/es
Priority to PT04766068T priority patent/PT1638582E/pt
Priority to ES04766068T priority patent/ES2322060T3/es
Priority to US10/561,670 priority patent/US10245280B2/en
Priority to PCT/EP2004/051209 priority patent/WO2005000321A1/en
Priority to PL04766068T priority patent/PL1638582T3/pl
Priority to SI200431112T priority patent/SI1638582T1/sl
Priority to CA2529441A priority patent/CA2529441C/en
Priority to CN200480017686XA priority patent/CN1812798B/zh
Priority to BRPI0411702A priority patent/BRPI0411702B8/pt
Priority to JP2006516177A priority patent/JP4728955B2/ja
Priority to EP04766068A priority patent/EP1638582B1/en
Priority to DE602004019528T priority patent/DE602004019528D1/de
Priority to DK04766068T priority patent/DK1638582T3/da
Priority to AT04766068T priority patent/ATE422892T1/de
Publication of ITMI20031291A1 publication Critical patent/ITMI20031291A1/it
Priority to CY20091100491T priority patent/CY1108992T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT001291A 2003-06-25 2003-06-25 Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale. ITMI20031291A1 (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT001291A ITMI20031291A1 (it) 2003-06-25 2003-06-25 Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
DK04766068T DK1638582T3 (da) 2003-06-25 2004-06-23 Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after
AT04766068T ATE422892T1 (de) 2003-06-25 2004-06-23 Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
SI200431112T SI1638582T1 (sl) 2003-06-25 2004-06-23 Uporaba hialuronske kisline za pripravo sestav za zdravljenje ponavljajoäśih se aft v ustni votlini
BRPI0411702A BRPI0411702B8 (pt) 2003-06-25 2004-06-23 uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral
ES04766068T ES2322060T3 (es) 2003-06-25 2004-06-23 Utilizacion de acido hilauronico en la preparacion de composiciones para el tratamiento de aftas recurrentes de la cavidad bucal.
US10/561,670 US10245280B2 (en) 2003-06-25 2004-06-23 Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
PCT/EP2004/051209 WO2005000321A1 (en) 2003-06-25 2004-06-23 Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
PL04766068T PL1638582T3 (pl) 2003-06-25 2004-06-23 Zastosowanie kwasu hialuronowego do wytwarzania środków do leczenia nawracających aft w jamie ustnej
MXPA05014184A MXPA05014184A (es) 2003-06-25 2004-06-23 Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral.
CA2529441A CA2529441C (en) 2003-06-25 2004-06-23 Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
CN200480017686XA CN1812798B (zh) 2003-06-25 2004-06-23 透明质酸在制备用于治疗口腔阿弗他溃疡的组合物中的应用
PT04766068T PT1638582E (pt) 2003-06-25 2004-06-23 Uso de ácido hialurónico para a preparação de composições para o tratamento de aftas recorrentes da cavidade bucal
JP2006516177A JP4728955B2 (ja) 2003-06-25 2004-06-23 口腔アフタの治療用の組成物を製造するためのヒアルロン酸の使用
EP04766068A EP1638582B1 (en) 2003-06-25 2004-06-23 Use of hyaluronic acid for preparing compositions for treating recurrent oral cavity aphthas
DE602004019528T DE602004019528D1 (de) 2003-06-25 2004-06-23 Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
CY20091100491T CY1108992T1 (el) 2003-06-25 2009-05-07 Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001291A ITMI20031291A1 (it) 2003-06-25 2003-06-25 Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.

Publications (2)

Publication Number Publication Date
ITMI20031291A0 true ITMI20031291A0 (it) 2003-06-25
ITMI20031291A1 ITMI20031291A1 (it) 2004-12-26

Family

ID=30131290

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001291A ITMI20031291A1 (it) 2003-06-25 2003-06-25 Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.

Country Status (17)

Country Link
US (1) US10245280B2 (it)
EP (1) EP1638582B1 (it)
JP (1) JP4728955B2 (it)
CN (1) CN1812798B (it)
AT (1) ATE422892T1 (it)
BR (1) BRPI0411702B8 (it)
CA (1) CA2529441C (it)
CY (1) CY1108992T1 (it)
DE (1) DE602004019528D1 (it)
DK (1) DK1638582T3 (it)
ES (1) ES2322060T3 (it)
IT (1) ITMI20031291A1 (it)
MX (1) MXPA05014184A (it)
PL (1) PL1638582T3 (it)
PT (1) PT1638582E (it)
SI (1) SI1638582T1 (it)
WO (1) WO2005000321A1 (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0309890A (pt) * 2002-05-09 2005-05-10 Medigenes Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
ITMI20081450A1 (it) * 2008-08-04 2010-02-05 Biofarmitalia Spa Pellicola solida a rapida dissoluzione nei liquidi
IT1396468B1 (it) * 2008-11-11 2012-12-14 Farma Derma Srl Uso topico di acido ialuronico ad azione filmogena in preparati per il trattamento e profilassi di patologie delle vie respiratorie.
ES2388281B1 (es) 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
JP5840107B2 (ja) * 2012-06-17 2016-01-06 コスメディ製薬株式会社 ヒアルロン酸ゲル及びその製造方法
CN103860526A (zh) * 2013-11-26 2014-06-18 华熙福瑞达生物医药有限公司 一种含透明质酸的消毒剂、其制备方法及用途
EP3056195A1 (en) 2015-02-13 2016-08-17 Vision:Organic GmbH Compositions comprising hyaluronic acid and beta-glucan for topical applications in oral cavity
ITUB20153699A1 (it) * 2015-09-17 2017-03-17 Fastmeditalia Srl Integratore orale
IT201700048750A1 (it) * 2017-05-05 2018-11-05 Farm Procemsa S P A Composizione per il trattamento di afte e ulcere buccali
GB201713362D0 (en) * 2017-08-21 2017-10-04 Givaudan Sa Improvements in or relating to organic compounds
CN108210689A (zh) * 2017-11-27 2018-06-29 南京天纵易康生物科技股份有限公司 一种含有透明质酸的口腔溃疡膜剂及其制备方法
EP4230212A1 (en) 2022-02-16 2023-08-23 UNIVERSITÄTSmedizin der Johannes Gutenberg- Universität Mainz Composition and kits for the prevention or treatment of gum diseases
IT202200010439A1 (it) * 2022-05-19 2023-11-19 Anatek Health Italia S R L Composizione comprendente acido nevronico e beta-cariofillene nel trattamento della mucosite
CN118490560A (zh) * 2024-05-08 2024-08-16 北京华熙荣熙生物技术研究有限公司 一种口腔护理组合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US183278A (en) 1876-10-17 Improvement in ventilating-cowls
IT1240316B (it) 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
US5972906A (en) * 1991-07-03 1999-10-26 Hyal Pharmaceutical Corporation Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
IT1318649B1 (it) 2000-07-28 2003-08-27 Propharma S R L Ora Sinclair P Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
US6828308B2 (en) 2000-07-28 2004-12-07 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment or prevention of inflammation

Also Published As

Publication number Publication date
CN1812798A (zh) 2006-08-02
EP1638582B1 (en) 2009-02-18
JP2009513492A (ja) 2009-04-02
ES2322060T3 (es) 2009-06-16
BRPI0411702B8 (pt) 2021-05-25
PL1638582T3 (pl) 2009-07-31
BRPI0411702B1 (pt) 2019-08-13
US10245280B2 (en) 2019-04-02
EP1638582A1 (en) 2006-03-29
SI1638582T1 (sl) 2009-10-31
CY1108992T1 (el) 2014-07-02
DK1638582T3 (da) 2009-05-18
CA2529441C (en) 2012-12-04
US20060147393A1 (en) 2006-07-06
MXPA05014184A (es) 2006-03-09
PT1638582E (pt) 2009-05-28
WO2005000321A1 (en) 2005-01-06
ITMI20031291A1 (it) 2004-12-26
BRPI0411702A (pt) 2006-08-08
CA2529441A1 (en) 2005-01-06
ATE422892T1 (de) 2009-03-15
CN1812798B (zh) 2011-02-09
DE602004019528D1 (de) 2009-04-02
JP4728955B2 (ja) 2011-07-20

Similar Documents

Publication Publication Date Title
ITMI20031291A0 (it) Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale
HUP0203437A3 (en) Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
HUP0401427A3 (en) Oral compositions for the treatment of scalp disorders
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
IL173110A0 (en) Semi-solid formulations for the oral administration of taxoids
AP2006003613A0 (en) Oral formulations for 5-HT-receptor agonists, usesand methods of treatment employing the same
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
ITMI20040013A1 (it) Procedimento per la preparazione di esteri dell'acido -met-acrilico
IT1317836B1 (it) Uso del tiamfenicolo per la preparazione di composizioni farmaceuticheutili per il trattamento di infezioni da staphylococci
ITBO20010361A0 (it) Uso di acido ialuronico per la produzione di un preparato ad uso vaginale, in particolare per la cura degli stati atrofici e distrofici cerv
GB0319566D0 (en) Use of oral care composition
EE05380B1 (et) FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid
ITMI20011379A0 (it) Procedimento per la preparazione del divalproato sodico
ECSP034769A (es) Composicion farmaceutica
GB0319565D0 (en) Use of oral care composition
ITBO20020022A1 (it) Composizioni farmaceutiche per la cura della pelle e il loro impiego
ITMI20021405A0 (it) Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato respiratorio
ITMI20052426A1 (it) Uso dell'ormone a-melanocito stimolante e-o suoi derivati o analoghi per la preparazione di composizioni farmaceutiche per il trattamento di patologie fibroproliferative
ITVI20030180A1 (it) Procedimento per la fabbricazione di protesi odontoiatriche
EP1670809A4 (en) SYNTHESIS AND PRODUCTION OF PENTOSTATIN, PRECURSORS, ANALOGS AND DERIVATIVES THEREOF
ITPA20030008A1 (it) Procedimento per la preparazione di creme di liquori
HUP0103049A3 (en) Use of fluexetine for preparation of pharmaceutical compositions
IT1318563B1 (it) Uso della n-acetilcisteina per la preparazione di composizionifarmaceutiche orali per il trattamento dell'asma.
ITPC20030026A1 (it) Composizione cementizia per la preparazione di